“showed a trend”

However, it still showed a trend in predicting OS ( P = 0.052).

TPS) alone did not influence LRC or PFS, patients with absent early hypoxia response and positive TPS exhibited significantly reduced LRC (HR = 3.374, 95% CI 1.192 - 9.548, p = 0.022) and showed a trend towards impaired PFS (HR = 2.752, 95% CI 0.992 - 7.631, p = 0.052).

It should be pointed out here that this is in disagreement with the fact that ECV showed a trend to be increased in patients with Perugini grade 3 compared to Perugini grade 2 ( p = 0.052).

However, mice receiving 5-ASA showed a trend towards lower plasma triglycerides (0.91±0.12 vs. 0.59±0.10, P = 0.052, Fig 1E ), whereas no effect was seen on the plasma levels of free ( Fig 1F ) and total cholesterol ( Fig 1G ). 5-ASA treatment improves plasma lipid levels in HFC-fed mice To assess whether 5-ASA may improve plasma lipid levels in the setting of diet-induced obesity (DIO), we challenged C57BL/6J mice with either a HFC diet or HFC incorporated with 5-ASA for 12 weeks.

In all patients, a low NK cytotoxicity level [ Figure 2(c) ] did not significantly predict the survival outcome (61.1% versus 70.2%, p = 0.347), while the ferritin level higher than 5500 ng/ml [ Figure 2(d) ] showed a trend for poorer OS (55.6% versus 71.3%, p = 0.052).

In FST2, 7 days later, swimming behavior showed a trend toward modulation by donepezil dose (one-way ANOVA: F(3, 28) = 2.91; p = 0.052), driven by a mild increase in swimming (relative to vehicle) for the low and medium doses, but a decrease at the high dose (and an inverted u-shaped dose-response curve with our shuffling test; see Table S2 ).

The complete re-sequencing of the 56 mtDNAs belonging to H5 revealed that AD patients showed a trend towards a higher number (p = 0.052) of sporadic mutations in tRNA and rRNA genes when compared with controls.

However, comparing accuracy in the first block of the task in both sessions directly, showed a trend-level difference [ t (18) = -2.071, p = 0.052, Bf = 1,352] with performance being higher in the second (mean A′: 0.85, SD : 0.035, range: 0.78–0.92) compared to the first session (mean A′: 0.83, SD : 0.033, range: 0.78–0.88).

ISI for decaffeinated coffee was significantly higher than for caffeine and showed a trend toward being lower than for placebo ( P = 0.052).

Involvement of Classical Complement Pathway RT-qPCR analyses of classical pathway components showed a trend towards an upregulation in the mRNA expression levels of C1qa in the ONA retinae (1.42-fold expression; p = 0.052).

3 ), in N0 patients, p53 + tumors showed a trend for better BCSS ( p = 0.052) and OS ( p = 0.079) compared to p53‐ tumors by the Kaplan–Meier method.

The intercept for the normalized vessel volume showed a trend to be lower in arteries than in veins ( p = 0.052).

At 5 min, all mucous doses significantly differed in comparison to saline (all P <0.05), except for the lowest dose, which showed a trend in the same direction as the other doses ( P =0.052).

However, high levels of the PDL1 + CTLA4 + LAG3 + subset both before (mPFS: 1.6 months vs 2.1 months in low levels, HR=1.971, p=0.010) and after treatment (mPFS: 2.9 months vs 4.5 months, HR=2.246, p=0.008) were also significantly associated with shorter PFS and showed a trend towards association with shorter OS (mOS: 9.0 months vs 15.6 months, HR=2.164, p=0.052; online supplemental figure S5B ).

In analysis of lymphocyte subset, a pattern of NK cell change between before and after CRT showed a trend for the association with nodal response (p = 0.052 by repeated measure analysis) ( Fig. 2 ).

A recent phase II trial for patients with residual disease or high-risk pCR after receiving neoadjuvant or postoperative anti-HER2 agents reported that the GP2 vaccine had no significant benefit in DFS in the total population, yet a subset analysis showed a trend toward improved DFS in the HER2+ group that received the GP2 vaccine ( p = 0.052) [ 46 ].

All brain:organ weight ratios were significantly greater in fetuses of low BW gilts, except the brain:kidney weight ratio, which showed a trend in the same direction ( P = 0.052) ( Table 2 ).

A surgical volume of ≥20 cases showed a trend toward favorable outcomes on cancer-specific survival [hazard ratio (HR) 0.154, p = 0.052] and marginal benefit for overall survival (HR 0.326, p = 0.019) in the multivariate analysis.

The peak ICH volume still showed a trend towards larger volumes in patients treated with mannitol (see Tables 5 and 21 (IQR 10–60) mL vs. 39 (IQR 16–59) mL, p = 0.052).

The risk of readmission showed a trend of increase for patients with a higher Z-score transformed SI (OR = 1.34 for a one SD increase in Z-score transformed SI, 95% CI = 1.00–1.79, P = 0.052).

In the unmatched cohort, CRT showed a trend toward improved DMFS (median 101.38 months versus 50.16 months, P = 0.052) and DMFI (101.38 months versus 53.25 months, P = 0.071).

High expression of TIM3 and VISTA showed a trend toward lower rates of SD ≥6 months/PR/CR (0 versus 52% in each case; p = .052) as did CD68 (albeit weaker; 0 versus 50%; p = .113) ( Table 4 ).

This analysis confirmed that in the ICI-treated cohort, higher CD40 expression was significantly associated with longer OS (HR 0.991, 95% CI 0.985–0.997; P = 0.003) and showed a trend toward improved PFS (HR 0.995, 95% CI 0.990–1.000; P = 0.052).

Although the Mini-Mental State Examination results showed a trend towards a significant score (p = 0.052), values were inside the normal range for both runs (27-30).

The abacavir-switch arm showed a trend for greater LSM reduction from baseline in free fatty acids (-0.3 vs -0.2 mEq/L; P = 0.052).